Lumos Diagnostics Holdings Limited (ASX:LDX)
Australia flag Australia · Delayed Price · Currency is AUD
0.1500
-0.0100 (-6.25%)
Apr 28, 2026, 4:10 PM AEST

ASX:LDX Revenue

Lumos Diagnostics Holdings had revenue of $6.12M USD in the half year ending December 31, 2025, with 121.26% growth. This brings the company's revenue in the last twelve months to $12.21M, down -16.75% year-over-year. In the fiscal year ending June 30, 2025, Lumos Diagnostics Holdings had annual revenue of $12.40M with 11.40% growth.

Revenue (ttm)
$12.21M
Revenue Growth
-16.75%
P/S Ratio
8.06
Revenue / Employee
n/a
Employees
n/a
Market Cap
147.63M AUD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202512.40M1.27M11.40%
Jun 30, 202411.13M596.00K5.66%
Jun 30, 202310.54M-1.10M-9.42%
Jun 30, 202211.63M-7.22M-38.32%
Jun 30, 202118.85M13.06M225.25%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
PolyNovo139.49M
SomnoMed118.50M
Aroa Biosurgery79.26M
Compumedics58.49M
Nova Eye Medical33.05M
CleanSpace Holdings20.66M
Micro-X16.90M
EMVision Medical Devices5.43M
Revenue Rankings